These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 10459160)

  • 21. Virus-Specific Antibody, Viral Load, and Disease Severity in Respiratory Syncytial Virus Infection.
    Walsh EE; Wang L; Falsey AR; Qiu X; Corbett A; Holden-Wiltse J; Mariani TJ; Topham DJ; Caserta MT
    J Infect Dis; 2018 Jun; 218(2):208-217. PubMed ID: 29546402
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A phase 1a, first-in-human, randomized study of a respiratory syncytial virus F protein vaccine with and without a toll-like receptor-4 agonist and stable emulsion adjuvant.
    Falloon J; Ji F; Curtis C; Bart S; Sheldon E; Krieger D; Dubovsky F; Lambert S; Takas T; Villafana T; Esser MT
    Vaccine; 2016 May; 34(25):2847-54. PubMed ID: 27102821
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of Electrochemiluminescent Serology Assays to Measure the Humoral Response to Antigens of Respiratory Syncytial Virus.
    Maifeld SV; Ro B; Mok H; Chu M; Yu L; Yamagata R; Leonardson T; Chio V; Parhy B; Park S; Carlson M; Machhi S; Ulbrandt N; Falsey AR; Walsh EE; Wang CK; Esser MT; Zuo F
    PLoS One; 2016; 11(4):e0153019. PubMed ID: 27070145
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A prospective surveillance study on the kinetics of the humoral immune response to the respiratory syncytial virus fusion protein in adults in Houston, Texas.
    Blunck BN; Aideyan L; Ye X; Avadhanula V; Ferlic-Stark L; Zechiedrich L; Gilbert BE; Piedra PA
    Vaccine; 2021 Feb; 39(8):1248-1256. PubMed ID: 33509697
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of serum neutralizing antibody in reinfection of respiratory syncytial virus.
    Kawasaki Y; Hosoya M; Katayose M; Suzuki H
    Pediatr Int; 2004 Apr; 46(2):126-9. PubMed ID: 15056236
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of neutralizing antibodies in adults with community-acquired pneumonia by respiratory syncytial virus.
    Luchsinger V; Piedra PA; Ruiz M; Zunino E; Martínez MA; Machado C; Fasce R; Ulloa MT; Fink MC; Lara P; Avendaño LF
    Clin Infect Dis; 2012 Apr; 54(7):905-12. PubMed ID: 22238168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Respiratory syncytial virus elicits enriched CD8+ T lymphocyte responses in lung compared with blood in African green monkeys.
    Li H; Callahan C; Citron M; Wen Z; Touch S; Monslow MA; Cox KS; DiStefano DJ; Vora KA; Bett A; Espeseth A
    PLoS One; 2017; 12(11):e0187642. PubMed ID: 29121080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Absence of Association between Cord Specific Antibody Levels and Severe Respiratory Syncytial Virus (RSV) Disease in Early Infants: A Case Control Study from Coastal Kenya.
    Nyiro JU; Sande CJ; Mutunga M; Kiyuka PK; Munywoki PK; Scott JA; Nokes DJ
    PLoS One; 2016; 11(11):e0166706. PubMed ID: 27851799
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improving ability of RSV microneutralization assay to detect G-specific and cross-reactive neutralizing antibodies through immortalized cell line selection.
    Boukhvalova MS; Mbaye A; Kovtun S; Yim KC; Konstantinova T; Getachew T; Khurana S; Falsey AR; Blanco JCG
    Vaccine; 2018 Jul; 36(31):4657-4662. PubMed ID: 29960801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Viral shedding and immune responses to respiratory syncytial virus infection in older adults.
    Walsh EE; Peterson DR; Kalkanoglu AE; Lee FE; Falsey AR
    J Infect Dis; 2013 May; 207(9):1424-32. PubMed ID: 23382572
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An Adjuvanted, Postfusion F Protein-Based Vaccine Did Not Prevent Respiratory Syncytial Virus Illness in Older Adults.
    Falloon J; Yu J; Esser MT; Villafana T; Yu L; Dubovsky F; Takas T; Levin MJ; Falsey AR
    J Infect Dis; 2017 Dec; 216(11):1362-1370. PubMed ID: 29029260
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Respiratory Syncytial Virus Vaccine Vectored by a Stable Chimeric and Replication-Deficient Sendai Virus Protects Mice without Inducing Enhanced Disease.
    Wiegand MA; Gori-Savellini G; Gandolfo C; Papa G; Kaufmann C; Felder E; Ginori A; Disanto MG; Spina D; Cusi MG
    J Virol; 2017 May; 91(10):. PubMed ID: 28250126
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhancement of mucosal and cellular immune response in mice by vaccination with respiratory syncytial virus DNA encapsulated with transfersome.
    Xu J; Ding Y; Yang Y
    Viral Immunol; 2008 Dec; 21(4):483-9. PubMed ID: 19115938
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preparation of a respiratory syncytial virus human reference serum for use in the quantitation of neutralization antibody.
    Yang DP; Zielinska E; Quiroz J; Madore D; Rappaport R
    Biologicals; 2007 Jun; 35(3):183-7. PubMed ID: 17241789
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transplacental transfer of maternal respiratory syncytial virus (RSV) antibody and protection against RSV disease in infants in rural Nepal.
    Chu HY; Tielsch J; Katz J; Magaret AS; Khatry S; LeClerq SC; Shrestha L; Kuypers J; Steinhoff MC; Englund JA
    J Clin Virol; 2017 Oct; 95():90-95. PubMed ID: 28903080
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kinetics of the neutralizing antibody response to respiratory syncytial virus infections in a birth cohort.
    Sande CJ; Mutunga MN; Okiro EA; Medley GF; Cane PA; Nokes DJ
    J Med Virol; 2013 Nov; 85(11):2020-5. PubMed ID: 23983183
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay.
    Do LAH; Tse R; Nathanielsz J; Anderson J; Ong DS; Chappell K; Mulholland K; Licciardi PV
    J Vis Exp; 2019 Jan; (143):. PubMed ID: 30741261
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibody response and avidity of respiratory syncytial virus-specific total IgG, IgG1, and IgG3 in young children.
    Freitas GR; Silva DA; Yokosawa J; Paula NT; Costa LF; Carneiro BM; Ribeiro LZ; Oliveira TF; Mineo JR; Queiróz DA
    J Med Virol; 2011 Oct; 83(10):1826-33. PubMed ID: 21837801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Randomized, Controlled, Observer-Blinded Phase 1 Study of the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine With or Without Alum Adjuvant.
    Langley JM; Aggarwal N; Toma A; Halperin SA; McNeil SA; Fissette L; Dewé W; Leyssen M; Toussaint JF; Dieussaert I
    J Infect Dis; 2017 Jan; 215(1):24-33. PubMed ID: 27694633
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Parainfluenza Virus 5 Expressing Wild-Type or Prefusion Respiratory Syncytial Virus (RSV) Fusion Protein Protects Mice and Cotton Rats from RSV Challenge.
    Phan SI; Zengel JR; Wei H; Li Z; Wang D; He B
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28747496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.